Cureus | Accuracy of Classifying Lung Carcinoma Using Immunohistochemical Markers on Limited Biopsy Material: A Two-Center Study | Article
p63 (Squamous, Basal & Myoepithelial Cell Marker) Ultraspecific Antibody Tested against >20,000 Human Proteins – enQuire BioReagents
The Use of P63 Immunohistochemistry for the Identification of Squamous Cell Carcinoma of the Lung | PLOS ONE
TTF-1 and p63 for distinguishing pulmonary small-cell carcinoma from poorly differentiated squamous cell carcinoma in previously pap-stained cytologic material | Modern Pathology
The p63 + CK5 antibody - Biocare Medical
Diagnostics | Free Full-Text | TTF-1/p63-Positive Poorly Differentiated NSCLC: A Histogenetic Hypothesis from the Basal Reserve Cell of the Terminal Respiratory Unit
Subtyping Non–Small Cell Lung Cancer: Relevant Issues and Operative Recommendations for the Best Pathology Practice - Giulio Rossi, Giuseppe Pelosi, Mattia Barbareschi, Paolo Graziano, Alberto Cavazza, Mauro Papotti, 2013
Effects of siRNA Silencing of TUG1 and LCAL6 Long Non-coding RNAs on Patient-derived Xenograft of Non–small Cell Lung Cancer | Anticancer Research
P63 - RMAB086R - Diagnostic BioSystems(dbiosys) DBS
IJMS | Free Full-Text | p63 Is a Promising Marker in the Diagnosis of Unusual Skin Cancer
Frontiers | Lung Cancer Stem Cell Markers as Therapeutic Targets: An Update on Signaling Pathways and Therapies
p63 expression in human tumors and normal tissues: a tissue microarray study on 10,200 tumors | Biomarker Research | Full Text
Pathology Outlines - p63
A combination of cytokeratin 5/6, p63, p40 and MUC5AC are useful for distinguishing squamous cell carcinoma from adenocarcinoma of the cervix | Diagnostic Pathology | Full Text
p63 expression in assessment of bronchioloalveolar proliferations of the lung | Modern Pathology
Pathology Outlines - p63
Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy - ScienceDirect
p63 expression in assessment of bronchioloalveolar proliferations of the lung | Modern Pathology
p63 IHC analysis with 4A4 antibody in lung tumorigenesis. A , bronchial... | Download Scientific Diagram
A panel of four immunohistochemical markers (CK7, CK20, TTF-1, and p63) allows accurate diagnosis of primary and metastatic lung carcinoma on biopsy specimens | SpringerLink
The Use of P63 Immunohistochemistry for the Identification of Squamous Cell Carcinoma of the Lung | PLOS ONE
Expression of P40 and P63 in lung cancers using fine needle aspiration cases. Understanding clinical pitfalls and limitations. - Abstract - Europe PMC
Diagnostics | Free Full-Text | TTF-1/p63-Positive Poorly Differentiated NSCLC: A Histogenetic Hypothesis from the Basal Reserve Cell of the Terminal Respiratory Unit
Immunohistochemistry stains in squamous cell carcinoma and... | Download Scientific Diagram
